Chronic kidney disease among people living with HIV on TDF based regimen: A systematic review and meta-analysis
PLOS ONE · 06.02.2025 · 20 (2) · e0318068
DOI: 10.1371/journal.pone.0318068 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS ONE, online erschienen am 06.02.2025. Verfasst von Taklo Simeneh Yazie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Pharmacology and Toxicology, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, HIV Infections, Tenofovir, Anti-HIV Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Chronic kidney disease is a major public health concern among people living with human immunodeficiency virus (PLWHIV) who are taking tenofovir disoproxil fumarate-based regimen. Despite the available evidence showing a high prevalence of CKD in this population, comprehensive pooled estimate of CKD among PLWHIV receiving TDF based regimen across the globe is lacking. Hence, the present systematic review aimed to provide a global pooled prevalence estimate of CKD.
Method
We conducted a systematic review of literatures published between January 2000 and May 2024. Articles and grey literature were searched from the following databases and search engine: PubMed, EMBASE, Scopus, Web of science, The Cumulative Index to Nursing and Allied Health Literature (CINHAL), and Google Scholar. We included eligible studies that report magnitude of CKD in TDF based regimen. We executed the pooled CKD, subgroup analysis, and funnel plot using random effect model. All statistical analysis including sensitivity analysis were made using Stata 17 software.
Results
Sixty-nine studies with 88299 participants included in this meta-analysis. The pooled prevalence of CKD was 7% (95% CI:6–8). CD4 count less than 200 copies per milliliter, and being female were associated with CKD.
Conclusion
We concluded that the magnitude of CKD across the globe is high in people living with HIV who have received TDF based regimen. Early identification of CKD by considering regular renal function monitoring, and risk factors especially low CD4 count, and female gender at birth are essential.
Trial registration
The protocol has been prospectively registered with PROSPERO (( CRD42020136813 ).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Pharmacology and Toxicology, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
- UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Herston, Australia.
- Department of Nursing, Asrat Weldeyes Health Science Campus, Debre Berhan University, Debre Berhan, Ethiopia.
- Department of Social and Public Health, College of Health Science, Debre Tabor University, Debre Tabor, Ethiopia.
- Department of Biomedical Science, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
- Department of Clinical Pharmacy, College of Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
ORCID-Profile: Taklo Simeneh Yazie, Assefa Agegnehu Teshome
Zitieren
APA
Yazie, T. S., Shiferaw, W. S., Gebeyehu, A. A., Teshome, A. A., Addisu, Z. D., & Belete, A. M. (2025). Chronic kidney disease among people living with HIV on TDF based regimen: A systematic review and meta-analysis. PLOS ONE, 20(2), e0318068. https://doi.org/10.1371/journal.pone.0318068
Vancouver
Yazie TS, Shiferaw WS, Gebeyehu AA, Teshome AA, Addisu ZD, Belete AM. Chronic kidney disease among people living with HIV on TDF based regimen: A systematic review and meta-analysis. PLOS ONE. 2025;20(2):e0318068. doi:10.1371/journal.pone.0318068
BibTeX
@article{Yazie2025,
author = {Yazie, Taklo Simeneh and Shiferaw, Wondimeneh Shibabaw and Gebeyehu, Asaye Alamneh and Teshome, Assefa Agegnehu and Addisu, Zenaw Debasu and Belete, Abebe Muche},
title = {Chronic kidney disease among people living with HIV on TDF based regimen: A systematic review and meta-analysis},
journal = {PLOS ONE},
year = {2025},
volume = {20},
number = {2},
pages = {e0318068},
doi = {10.1371/journal.pone.0318068}
}
EUVIMED